Joseph Lambing files SEC Form 4 disclosures for MyoKardia Inc. They have made 5 open-market trades across 1 company since 2017, most recently 2019-01-07.
CIK 0001655816
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MYOK | 94,740 | $21.3M |
Shares reported on the most recent Form 4, priced at the 2019-01-09 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MYOK | SELL | 2018-02-26 | 2018-02-28 | $60.00 | $138K | -12.0% | -16.4% | -18.9% |
| MYOK | SELL | 2018-01-12 | 2018-01-16 | $50.00 | $250K | +2.1% | +3.8% | -6.3% |
| MYOK | SELL | 2017-08-22 | 2017-08-24 | $45.00 | $225K | -8.2% | -5.4% | -21.1% |
| MYOK | SELL | 2017-08-15 | 2017-08-16 | $40.00 | $200K | +5.8% | +9.9% | -11.7% |
| MYOK | SELL | 2017-08-07 | 2017-08-09 | $30.00 | $450K | +19.5% | +18.4% | +7.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.